Abhi Chandrasekhara
Investment Professional @ Victory Park Capital
New York, United States
Abhi Chandrasekhara is an Investment Professional at Victory Park Capital. He attended The University of Chicago Booth School of Business, University of Maryland - Robert H. Smith School of Business and University of Maryland.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries Abhi Chandrasekhara invests in
Stages Abhi Chandrasekhara invests in
Countries Abhi Chandrasekhara invests in
Investment Focus
Industry
- Advice 1 (14%)
- Farming 1 (14%)
- Wholesale 1 (14%)
- Consulting 1 (14%)
- Agriculture 1 (14%)
Stage
- Funding Round 2 (29%)
- Debt Financing 2 (29%)
- Series C 1 (14%)
- Convertible Note 1 (14%)
- Venture - Series Unknown 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GaXtracts
|
GaXtracts is a pharmaceutical ingredients company that manufactures and processes products from industrial hemp.It focuses on the production of CBD and hemp-derived products while producing a medical-grade hand sanitizer since the start of the COVID-19 crisis, helping to fill an urgent market need for hospitals, law enforcement, first responders,and assisted living and home health care businesses. The company partners with farmers, who are experts in cultivation, to purchase their finest organic hemp crops. From there, the company’s pharmaceutical-grade facility takes the plant through an extraction process that removes the CBD molecules and creates a viable essential ingredient for many of today's cutting-edge products.The company is located in Atlanta, Georgia in 2019. | $200K / Venture - Series Unknown / May 18, 2020 | |
|
GaXtracts
|
GaXtracts is a pharmaceutical ingredients company that manufactures and processes products from industrial hemp.It focuses on the production of CBD and hemp-derived products while producing a medical-grade hand sanitizer since the start of the COVID-19 crisis, helping to fill an urgent market need for hospitals, law enforcement, first responders,and assisted living and home health care businesses. The company partners with farmers, who are experts in cultivation, to purchase their finest organic hemp crops. From there, the company’s pharmaceutical-grade facility takes the plant through an extraction process that removes the CBD molecules and creates a viable essential ingredient for many of today's cutting-edge products.The company is located in Atlanta, Georgia in 2019. | $1.8M / Debt Financing / May 18, 2020 | |
Cultiva
|
Cultiva™ has a proprietary technology called SureSeal™ designed to supplement the cuticle of the plant. Our product Parka™ – powered by SureSeal – is now used commercially on multiple high value crops to improve fruit quality and finish, suppress rain cracking, increase marketable yields and prolong shelf life. | $2.9M / Apr 23, 2020 | |
|
Cultiva
|
Cultiva™ has a proprietary technology called SureSeal™ designed to supplement the cuticle of the plant. Our product Parka™ – powered by SureSeal – is now used commercially on multiple high value crops to improve fruit quality and finish, suppress rain cracking, increase marketable yields and prolong shelf life. | $2.9M / Series C / Apr 23, 2020 | |
Danimer Scientific
|
Danimer Scientific produces a new generation of patented, cost competitive biopolymers. They also offer research, development, and toll manufacturing services for bio-based materials to business partners. They are committed to closed-loop, renewable and sustainable practices, and to products designed to help curb petrochemical plastic pollutionworldwide. Their plant and microbial sourced plastics are biodegradable, durable, and adaptable to a wide range of applications. Their toxin-free manufacturing practices are cost competitive. Their products are FDA approved for food contact, and certified to be aerobically and anaerobically biodegradable or compostable in soil, water, and industrial or home compost by ASTM, OWS, and Vinçotte. | $6.5M / Mar 18, 2019 | |
|
Danimer Scientific
|
Danimer Scientific produces a new generation of patented, cost competitive biopolymers. They also offer research, development, and toll manufacturing services for bio-based materials to business partners. They are committed to closed-loop, renewable and sustainable practices, and to products designed to help curb petrochemical plastic pollutionworldwide. Their plant and microbial sourced plastics are biodegradable, durable, and adaptable to a wide range of applications. Their toxin-free manufacturing practices are cost competitive. Their products are FDA approved for food contact, and certified to be aerobically and anaerobically biodegradable or compostable in soil, water, and industrial or home compost by ASTM, OWS, and Vinçotte. | Debt Financing / Mar 18, 2019 | |
|
Cultiva
|
Cultiva™ has a proprietary technology called SureSeal™ designed to supplement the cuticle of the plant. Our product Parka™ – powered by SureSeal – is now used commercially on multiple high value crops to improve fruit quality and finish, suppress rain cracking, increase marketable yields and prolong shelf life. | Convertible Note / Mar 01, 2017 |
About Victory Park Capital
Victory Park Capital (VPC) specializes in asset-backed lending, which includes small business and consumer finance, financial and hard asset loans, and real estate financing.
Victory Park Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Thomas Welch
Partner
|
|||
|
Abhi Chandrasekhara
Investment Professional
|
|||
Brendan Carroll
Partner
|
|||
|
Gordon Watson
Partner
|
|||
Hugo Lestiboudois
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Abhi Chandrasekhara invest in?
Abhi Chandrasekhara invests primarily in Advice, Farming and Wholesale startups, most often at Funding Round and Debt Financing stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Abhi Chandrasekhara last invest?
The most recent investment recorded for Abhi Chandrasekhara closed in May 2020. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
